Pure Global AI
Disease / condition

Solid Tumor clinical trials

Free access to 440 studies10+ countriesUpdated daily166 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
440
Total trials
10+
Countries
10+
Sponsors
166
Recruiting
By phase
Phase 1275
N/A49
Phase 243
Phase 1/242
Early Phase 124
By status
Recruiting166
Completed119
Not yet recruit...82
Terminated26
Unknown26
Top countries
China127
United States of America122
Japan18
South Korea16
France8
Top sponsors
Jiangsu HengRui Me...11
Eli Lilly and Comp...9
Hoffmann-La Roche8
Athenex, Inc.8
Genentech, Inc.7
Recent trials
Latest clinical trials for Solid Tumor
Dose-escalation Study of Ultra-high Dose Ablative Radiosurgery With Immunotherapy for Bulky Metastatic Cancer Patients
University of Kansas Medical C... · United States of America
NCT06416436Not yet recr...
Phase
Phase 1
Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of FTL001
Sound Biopharmaceuticals Ltd. · China
NCT06410092Recruiting
Phase
Phase 1
A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors
Fudan University · China
NCT06394622Recruiting
Phase
Phase 1
PD-L1 Specific [68Ga]-Nb-1 Nanobody Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospi... · China
NCT06383598Recruiting
A Phase 1/2 Study of PBI-410 in Advanced Solid Tumors
Pyramid Biosciences · United States of America
NCT06384807Not yet recr...
Phase
Phase 1/2
A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors
Astellas Pharma Inc · United States of America
NCT06364696Recruiting
Phase
Phase 1
A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors
Guangzhou Virotech Pharmaceuti... · China
NCT06368921Recruiting
Phase
Phase 1
Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors
Sichuan University
NCT06349837Not yet recr...
Phase
Phase 1
A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Actym Therapeutics, Inc. · Australia
NCT06336148Not yet recr...
Phase
Phase 1
HS-IT101 Injection in the Treatment of Advanced Solid Tumors
Qingdao Sino-Cell Biomedicine ... · China
NCT06342336Recruiting
Phase
Phase 1
A Study on Tuvusertib (Oral ATR Inhibitor) in Combination With PLX038 (Topo1 Inhibitor) in Patients With Advanced Solid Tumors
Institut Curie · France
NCT06337630Not yet recr...
Phase
Phase 1
An Exploratory Study by Fast CAR T Cells
Shanghai Cell Therapy Group Co... · China
NCT06327997Recruiting
Phase
Phase 1
What Unmet Need for the Patients?A Focus on the Social Determinants of Health in Phase 1 Clinical Trials
European Institute of Oncology · Italy
NCT06326242Recruiting
Online Proton Adaptive Radiotherapy
Washington University School o... · United States of America
NCT06310655Recruiting
M1774 Human Mass Balance Study (DDRIVER Solid Tumors 303)
Merck Healthcare KGaA, Darmsta... · Hungary
NCT06308263Recruiting
Phase
Phase 1
Study of STP938 in Advanced Solid Tumours
Step Pharma, SAS
NCT06297525Not yet recr...
Phase
Phase 1
Study of the RNR Inhibitor BBI-825 in Subjects With Tumors With Resistance Gene Amplifications
Boundless Bio · United States of America
NCT06299761Recruiting
Phase
Phase 1
Study of 23ME-01473 in Patients With Advanced Solid Malignancies
23andMe, Inc. · United States of America
NCT06290388Recruiting
Phase
Phase 1/2
An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells
Shanghai Cell Therapy Group Co... · China
NCT06249256Recruiting
Phase
Phase 1
Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors
Shanghai Cell Therapy Group Co... · China
NCT06248697Recruiting
Phase
Phase 1
View all 440 trials →
About this profile

Access comprehensive clinical trial information for Solid Tumor through Pure Global AI's free database. This collection includes 440 clinical trials across multiple phases including Phase 1, N/A, Phase 2. Currently, 166 trials are actively recruiting participants.

Research for Solid Tumor is being conducted in China, United States of America, Japan and 7+ other countries. Leading sponsors include Jiangsu HengRui Medicine Co., Ltd. and Eli Lilly and Company. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 440 clinical trials studying Solid Tumor, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Jiangsu HengRui Medicine Co., Ltd., Eli Lilly and Company, Hoffmann-La Roche, among others.